Novo Nordisk's Weight Loss Drug Wegovy Launches in UK Amid High Demand and Limited Supply
- The weight loss drug Wegovy, made by Novo Nordisk, has launched in a limited capacity in the UK market.
- Wegovy will be available through the NHS and privately, but supply constraints are expected to persist.
- In clinical trials, Wegovy helped patients lose approximately 15% of their body weight when combined with diet and exercise.
- Demand has outpaced supply for Wegovy in other markets like the US, Denmark, and Germany.
- Some experts worry limited availability in the UK could exacerbate health inequalities if access is easier for wealthy patients.
Semafor 
The Messenger 
Fortune 
Reuters 
CNN 
Barron's 
Washington Post 
Business Insider 
CNBC 
Forbes 
